Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

ADME Toxicology Testing Market Size Forecast: How Large Could The Market Become By 2030?

In the realm of adme toxicology testing, a significant upswing in market valuation has been observed lately. Projections indicate a substantial increase from its $11.5 billion standing in 2025 to $12.83 billion by 2026, fueled by a compound annual growth rate (CAGR) of 11.6%. The expansion witnessed during the preceding period was propelled by several key factors, including the restricted accessibility of automated adme testing methodologies, a continued dependency on conventional biochemical analyses, an intensified regulatory emphasis on the safety of pharmaceutical products, escalating investments in drug discovery research, and the widespread integration of sophisticated analytical tools like lc-ms and hplc.

The adme toxicology testing market is on a trajectory for substantial expansion, projected to reach $20.25 billion by the year 2030, fueled by a compound annual growth rate of 12.1%. This anticipated growth throughout the forecast period is largely driven by advancements such as the ongoing development of comprehensive adme platforms, the increasing utilization of omics and molecular imaging technologies, augmented investments in predictive toxicology software, the broadening application of adme testing within the cosmetics and food sectors, and the widespread adoption of AI-powered solutions for risk assessment. Key trends shaping this market landscape include a heightened embrace of high-throughput screening instruments, a greater reliance on cell-based and in vitro assays, a surge in demand for omics-driven toxicology methodologies, the expanding role of adme testing in pharmaceutical research and development, and the seamless integration of simulation and modeling software into risk assessment procedures.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11922&type=smp

ADME Toxicology Testing Market Opportunity Drivers: What Is Creating New Revenue Potential?

The expanding pharmaceutical sector is anticipated to fuel the expansion of the ADME toxicology testing market in the future, as this industry framework encompasses the identification, creation, and manufacturing of medications. ADME toxicology assessments are employed within this industry to scrutinize the absorption, distribution, metabolism, and excretion (ADME) characteristics of potential drug compounds and to gauge their associated risks of toxicity. Such evaluations are paramount for forecasting a drug’s behavior within the human system, encompassing its uptake speed, movement to specific tissues, metabolic transformation, and eventual clearance. Illustrating this trend, data from June 2023, provided by the European Federation of Pharmaceutical Industries and Associations (EFPIA), indicated that the overall pharmaceutical output in Europe reached €390,000 million ($422,803 million) for 2023, an increase from the €363,300 million ($393,857 million) recorded in 2022; consequently, the flourishing pharmaceutical industry is a key impetus for the growth observed in the ADME toxicology testing market.

ADME Toxicology Testing Market Segments: Where Are The Largest Growth Opportunities?

The adme toxicology testing market covered in this report is segmented –

1) By Product Type: Instruments, Software Solutions, Assays Systems, Reagents, Other Product Types

2) By Method: Cellular Assay, Biochemical Assay, In Silica, Ex-Vivo

3) By Technology: Cell Culture, High Throughput, Molecular Imaging, OMICS Technology, Other Technologies

4) By Application: Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity, Other Applications

5) By End-User: Cosmetics And Household Products, Pharmaceutical Industry, Animal Industry, Food Industry, Other End Users

Subsegments:

1) By Instruments: High-Throughput Screening Instruments, LC-MS Or MS (Liquid Chromatography-Mass Spectrometry), HPLC (High-Performance Liquid Chromatography), Automated Workstations

2) By Software Solutions: Data Management Software, Simulation And Modeling Software, Risk Assessment Software

3) By Assay Systems: Cell-Based Assays, In Vitro Assays, Bioanalytical Assays

4) By Reagents: Biochemicals, Buffer Solutions, Culture Media

5) By Other Products: Kits And Consumables, Analytical Standards

ADME Toxicology Testing Market Innovation Trends Driving Future Development

The ADME toxicology testing market, driven by key players, is witnessing the deployment of cutting-edge solutions like the Cyprotex e-Store, facilitating online procurement of ADME-Tox services. These services are designed to curtail both financial expenditure and development timelines, minimize the probability of late-stage setbacks, and ensure the selection of optimal drug candidates for clinical progression. A prime illustration of this trend is Evotec SE’s introduction in October 2023 of the Cyprotex e-Store, a digital marketplace offering streamlined online access to their extensive portfolio of ADME-Tox services. This e-commerce initiative expedites and simplifies the acquisition process, granting authenticated users the capability to review and order Cyprotex’s services at any time, day or night. The platform provides immediate online visibility into pricing and detailed procedural information, enabling users to effortlessly place orders, monitor their status, and efficiently reorder as required. Consequently, this optimized system shortens the turnaround time for services, thereby accelerating data delivery to users.

ADME Toxicology Testing Market Major Participants And Competitive Dynamics

Major companies operating in the adme toxicology testing market are AbbVie Inc., Thermo Fisher Scientific Inc., Boehringer Ingelheim GmbH, Laboratory Corporation of America Holdings, Corning Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Lonza Group AG, Dassault Systèmes SE, Catalent Inc., Charles River Laboratories International Inc., Beckman Coulter Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Curia Global Inc, Promega Corporation, Takara Bio Inc, AB Sciex LLC, QPS Holdings LLC, Simulations Plus Inc., Cyprotex, XenoTech LLC, BioIVT LLC, Absorption Systems, Creative Bioarray, SOLVO Biotechnology Rt., Creative Biolabs Inc, Gentronix Limited, Admecell Inc., Molecular Discovery Ltd.

Access The Complete ADME Toxicology Testing Market Report:

https://www.thebusinessresearchcompany.com/report/adme-toxicology-testing-global-market-report

ADME Toxicology Testing Market Regional Analysis: Which Region Leads By Revenue?

North America was the largest region in the ADME toxicology testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the adme toxicology testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model